Sedana Medical AB Interim report January-June 2022
Committed to change the standard of care, with commercial progress and a strong balance sheet.Second quarter 2022 · Net sales for the quarter totalled MSEK 27 (40), equivalent to a decrease of 32% compared to 2021. At constant exchange rates, sales decreased by 34%. The decrease is a consequence of a significant decline in ventilated patients in intensive care units. · Gross profit was MSEK 19 (26), equivalent to a margin of 70% (66%). The improved margin is mainly an effect of a positive product mix, price adjustments and initiatives to reduce freight costs. · Earnings before